These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 1156055

  • 1. Response to dopamine hydrochloride in the hepatorenal syndrome.
    Bennett WM, Keeffe E, Melnyk C, Mahler D, Rösch J, Porter GA.
    Arch Intern Med; 1975 Jul; 135(7):964-71. PubMed ID: 1156055
    [Abstract] [Full Text] [Related]

  • 2. [Clinical and experimental investigations of the effect of dopamine on haemodynamics and function of kidney and liver (author's transl)].
    Peschl L.
    Wien Klin Wochenschr Suppl; 1978 Jul; 86():1-33. PubMed ID: 274863
    [Abstract] [Full Text] [Related]

  • 3. [Treatment of hepatorenal syndrome with dopamine and bromocriptine].
    Uribe M, Moreno Berthier J, Guevara L, Ramírez-Acosta J, Márquez MA, Arce A.
    Rev Gastroenterol Mex; 1979 Jul; 44(2):63-6. PubMed ID: 379956
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Enhanced external counterpulsation: a new technique to augment renal function in liver cirrhosis.
    Werner D, Trägner P, Wawer A, Porst H, Daniel WG, Gross P.
    Nephrol Dial Transplant; 2005 May; 20(5):920-6. PubMed ID: 15788437
    [Abstract] [Full Text] [Related]

  • 6. Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation.
    Testino G, Ferro C, Sumberaz A, Messa P, Morelli N, Guadagni B, Ardizzone G, Valente U.
    Hepatogastroenterology; 2003 May; 50(54):1753-5. PubMed ID: 14696397
    [Abstract] [Full Text] [Related]

  • 7. Impact of pretransplant renal function on survival after liver transplantation.
    Gonwa TA, Klintmalm GB, Levy M, Jennings LS, Goldstein RM, Husberg BS.
    Transplantation; 1995 Feb 15; 59(3):361-5. PubMed ID: 7871566
    [Abstract] [Full Text] [Related]

  • 8. [Decrease in medio-renal and cortical renal blood flow in liver cirrhosis. Relationships with changes in systemic hemodynamics].
    Zuin R, Merkel C, Grassetto M, Milani L, Merlo A, Gatta A.
    Minerva Nefrol; 1979 Feb 15; 26(1):41-4. PubMed ID: 381991
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Terlipressin and albumin vs albumin in patients with cirrhosis and hepatorenal syndrome: a randomized study.
    Martín-Llahí M, Pépin MN, Guevara M, Díaz F, Torre A, Monescillo A, Soriano G, Terra C, Fábrega E, Arroyo V, Rodés J, Ginès P, TAHRS Investigators.
    Gastroenterology; 2008 May 15; 134(5):1352-9. PubMed ID: 18471512
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Low-dose dopamine infusion in cirrhosis with refractory ascites.
    Lin SM, Lee CS, Kao PF.
    Int J Clin Pract; 1998 May 15; 52(8):533-6. PubMed ID: 10622049
    [Abstract] [Full Text] [Related]

  • 13. [Clinical and functional aspects of the kidney in relation to renal and intrarenal hemodynamic changes during hepatic cirrhosis].
    Gatta A, Merkel C, Milani L, Caregaro L, Grassetto M, Lauro S, Zuin R.
    Minerva Nefrol; 1979 May 15; 26(1):37-40. PubMed ID: 381990
    [No Abstract] [Full Text] [Related]

  • 14. Renal function and structure in subacute hepatic failure.
    Bal C, Longkumer T, Patel C, Gupta SD, Acharya SK.
    J Gastroenterol Hepatol; 2000 Nov 15; 15(11):1318-24. PubMed ID: 11129228
    [Abstract] [Full Text] [Related]

  • 15. Transplantation of cadaveric kidneys from patients with hepatorenal syndrome. Evidence for the functionalnature of renal failure in advanced liver disease.
    Koppel MH, Coburn JW, Mims MM, Goldstein H, Boyle JD, Rubini ME.
    N Engl J Med; 1969 Jun 19; 280(25):1367-71. PubMed ID: 4890476
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Renal and humoral effects of ibopamine, a dopamine agonist, in patients with liver cirrhosis.
    Salerno F, Incerti P, Badalamenti S, Lorenzano E, Graziani G, Morganti A, Ghirardi P.
    Arch Intern Med; 1990 Jan 19; 150(1):65-9. PubMed ID: 1967522
    [Abstract] [Full Text] [Related]

  • 18. [Morpho-functional study of the kidney in patients with kidney disease and liver disease with magnetic resonance].
    Shariat Razavi I, Stacul F, Cova M, Artero M, Carraro M, Malalan F, Pozzi Mucelli R, Dalla Palma L.
    Radiol Med; 1998 Jan 19; 95(1-2):72-81. PubMed ID: 9636731
    [Abstract] [Full Text] [Related]

  • 19. The effects of chronic treatment with octreotide versus octreotide plus midodrine on systemic hemodynamics and renal hemodynamics and function in nonazotemic cirrhotic patients with ascites.
    Kalambokis G, Economou M, Fotopoulos A, Al Bokharhii J, Pappas C, Katsaraki A, Tsianos EV.
    Am J Gastroenterol; 2005 Apr 19; 100(4):879-85. PubMed ID: 15784036
    [Abstract] [Full Text] [Related]

  • 20. Reversal of type 1 hepatorenal syndrome with the administration of midodrine and octreotide.
    Angeli P, Volpin R, Gerunda G, Craighero R, Roner P, Merenda R, Amodio P, Sticca A, Caregaro L, Maffei-Faccioli A, Gatta A.
    Hepatology; 1999 Jun 19; 29(6):1690-7. PubMed ID: 10347109
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.